Get started
BOSTON SCIENTIFICBOSTON SCIENTIFICBOSTON SCIENTIFIC

BOSTON SCIENTIFIC

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals Bonds

4BSX chart


Full chart

Key facts today


Piper Sandler and TD Cowen have raised their price targets for Boston Scientific, maintaining an 'Overweight' rating. Analysts report an average 'buy' rating, with a mean target of $105.58.
Analyze the impactAnalyze the impact

4BSX upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪145.65 B‬ EUR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
85.0
Basic EPS (TTM)
1.0 EUR
Net income (FY)
‪1.44 B‬ EUR
Revenue (FY)
‪12.90 B‬ EUR
Shares float
‪1.47 B‬
Beta (1Y)
0.72

Employees


Employees (FY)
‪48 K‬
Change (1Y)
‪+3 K‬ +6.67%
Revenue / Employee (1Y)
‪268.78 K‬ EUR
Net income / Employee (1Y)
‪30.07 K‬ EUR

About Boston Scientific Corporation


Sector
Health Technology
Industry
Medical Specialties
CEO
Michael F. Mahoney
Website
bostonscientific.com
Headquarters
Marlborough
Founded
1979
FIGI
BBG00PG1KND7
Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. The MedSurg segment includes Endoscopy, Urology, and Neuromodulation. The Cardiovascular segment consists of Cardiology and Peripheral Interventions. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979 and is headquartered in Marlborough, MA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

4BSX news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

4BSX highest yielding bonds


BSX4801034
Boston Scientific Corporation 4.7% 01-MAR-2049
Yield to maturity
5.77%
Maturity date
Mar 1, 2049
BSX4801033
Boston Scientific Corporation 4.55% 01-MAR-2039
Yield to maturity
5.62%
Maturity date
Mar 1, 2039
BSX.GE
Boston Scientific Corporation 6.5% 15-NOV-2035
Yield to maturity
5.29%
Maturity date
Nov 15, 2035
BSX.GJ
Boston Scientific Corporation 7.375% 15-JAN-2040
Yield to maturity
5.20%
Maturity date
Jan 15, 2040
BSX4988126
Boston Scientific Corporation 2.65% 01-JUN-2030
Yield to maturity
5.14%
Maturity date
Jun 1, 2030
BSX4800733
Boston Scientific Corporation 4.0% 01-MAR-2029
Yield to maturity
4.88%
Maturity date
Mar 1, 2029
BSX4602368
Boston Scientific Corporation 4.0% 01-MAR-2028
Yield to maturity
4.78%
Maturity date
Mar 1, 2028
BSX4800732
Boston Scientific Corporation 3.75% 01-MAR-2026
Yield to maturity
4.75%
Maturity date
Mar 1, 2026
BSX4988125
Boston Scientific Corporation 1.9% 01-JUN-2025
Yield to maturity
4.64%
Maturity date
Jun 1, 2025
CH0A
AMERICAN MEDICAL SYSTEMS EUROPE B.V. 2022-08.03.34 GUARANTEED
Yield to maturity
3.53%
Maturity date
Mar 8, 2034
A
XS277226669
A.MED.SYS.EU 24/32
Yield to maturity
3.23%
Maturity date
Mar 8, 2032

Explore more bonds 

Frequently Asked Questions


The current price of 4BSX is 100.0 EUR — it has increased by 1.01% in the past 24 hours. Watch BOSTON SCIENTIFIC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on EUROTLX exchange BOSTON SCIENTIFIC stocks are traded under the ticker 4BSX.
4BSX stock has risen by 3.63% compared to the previous week, the month change is a 13.64% rise, over the last year BOSTON SCIENTIFIC has showed a 67.62% increase.
We've gathered analysts' opinions on BOSTON SCIENTIFIC future price: according to them, 4BSX price has a max estimate of 114.89 EUR and a min estimate of 86.89 EUR. Watch 4BSX chart and read a more detailed BOSTON SCIENTIFIC stock forecast: see what analysts think of BOSTON SCIENTIFIC and suggest that you do with its stocks.
4BSX reached its all-time high on Jan 31, 2025 with the price of 99.0 EUR, and its all-time low was 23.0 EUR and was reached on Mar 23, 2020. View more price dynamics on 4BSX chart.
See other stocks reaching their highest and lowest prices.
4BSX stock is 1.00% volatile and has beta coefficient of 0.72. Track BOSTON SCIENTIFIC stock price on the chart and check out the list of the most volatile stocks — is BOSTON SCIENTIFIC there?
Today BOSTON SCIENTIFIC has the market capitalization of ‪146.88 B‬, it has increased by 1.80% over the last week.
Yes, you can track BOSTON SCIENTIFIC financials in yearly and quarterly reports right on TradingView.
BOSTON SCIENTIFIC is going to release the next earnings report on Feb 5, 2025. Keep track of upcoming events with our Earnings Calendar.
4BSX earnings for the last quarter are 0.57 EUR per share, whereas the estimation was 0.53 EUR resulting in a 7.08% surprise. The estimated earnings for the next quarter are 0.63 EUR per share. See more details about BOSTON SCIENTIFIC earnings.
BOSTON SCIENTIFIC revenue for the last quarter amounts to ‪3.78 B‬ EUR, despite the estimated figure of ‪3.63 B‬ EUR. In the next quarter, revenue is expected to reach ‪4.27 B‬ EUR.
4BSX net income for the last quarter is ‪421.23 M‬ EUR, while the quarter before that showed ‪302.49 M‬ EUR of net income which accounts for 39.26% change. Track more BOSTON SCIENTIFIC financial stats to get the full picture.
No, 4BSX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Feb 4, 2025, the company has ‪48.00 K‬ employees. See our rating of the largest employees — is BOSTON SCIENTIFIC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BOSTON SCIENTIFIC EBITDA is ‪3.47 B‬ EUR, and current EBITDA margin is 23.71%. See more stats in BOSTON SCIENTIFIC financial statements.
Like other stocks, 4BSX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BOSTON SCIENTIFIC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BOSTON SCIENTIFIC technincal analysis shows the strong buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BOSTON SCIENTIFIC stock shows the strong buy signal. See more of BOSTON SCIENTIFIC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.